<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Glucosamine supplements may speed memory loss from Alzheimer’s: Study — Live Feed</title><link>https://www.live-feeds.com/feed/glucosamine-supplements-may-speed-memory-loss-from-alzheimer-s-study</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/glucosamine-supplements-may-speed-memory-loss-from-alzheimer-s-study/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Glucosamine supplements tied to faster Alzheimer’s decline, higher death risk in users</title><link>https://www.live-feeds.com/feed/glucosamine-supplements-may-speed-memory-loss-from-alzheimer-s-study</link><guid isPermaLink="false">https://www.live-feeds.com/feed/glucosamine-supplements-may-speed-memory-loss-from-alzheimer-s-study#u1376</guid><pubDate>Tue, 16 Jun 2026 15:41:48 +0000</pubDate><description>A study links glucosamine—a common joint supplement—to accelerated cognitive decline and a 25% higher five-year mortality rate among Alzheimer’s patients. Researchers warn it may worsen brain glycosylation, a process linked to dementia. No regulatory guidance has been issued. New reports amplify concerns but do not add substantiated details.What's confirmed:Glucosamine supplements, widely used for joint pain, may accelerate Alzheimer’s progression and increase the five-year mortality rate by 25% in users.The supplement is linked to abnormal brain glycosylation, a process associated with dement</description></item>
<item><title>Glucosamine linked to faster Alzheimer’s memory loss and higher death risk in new study</title><link>https://www.live-feeds.com/feed/glucosamine-supplements-may-speed-memory-loss-from-alzheimer-s-study</link><guid isPermaLink="false">https://www.live-feeds.com/feed/glucosamine-supplements-may-speed-memory-loss-from-alzheimer-s-study#u950</guid><pubDate>Tue, 16 Jun 2026 08:21:33 +0000</pubDate><description>A study published in *Nature Metabolism* finds glucosamine supplements—commonly used for joint pain—may accelerate cognitive decline in Alzheimer’s patients. Research shows a 25% higher five-year mortality rate among users and links glucosamine to abnormal brain glycosylation, a process tied to dementia progression. Experts warn the supplement may harm diseased brains while posing no clear risk to healthy ones. Regulatory or consumer guidance has not yet been issued.What's confirmed:People with Alzheimer’s who took glucosamine were 25% more likely to die within five years than non-users, accor</description></item>
</channel></rss>